Related Experiment Video
Updated: Oct 19, 2025

Isolation and Identification of Extravascular Immune Cells of the Heart
Published on: August 23, 2018
Autophagy in cardiac myxoma: An important puzzle piece in understanding its inflammatory environment
Viviana Sramek1, Maroa Dridi1, Alexandra Papoudou-Bai2
1Pathology Department, University Hospital of Saint-Etienne, France.
Background:
Cardiac myxomas are rare, predominantly sporadic tumors that can cause heart failure and systematic inflammatory symptoms, and increase the risk of emboli. Their pathophysiology remains poorly understood, but intra-tumoral inflammation and senescence seem to be implicated in it. One of the principal cellular mechanisms implicated in tumor progression is autophagy, largely unknown in myxomas. Thus, our study aimed to investigate the presence of autophagic markers in myxomas and to correlate it with their immune microenvironment.
Methods:
Twenty-five cardiac myxomas were studied for the autophagic markers LC3B and p62/sequestosome 1 and were compared with markers of the immune microenvironment.
Results:
Most myxomas showed expression of both autophagic markers. We found a positive correlation between LC3B and PD-L1, as well as CD163, and a negative correlation between LC3B and CD8, CD20, CD138, and CD117 infiltration.
Conclusion:
Our data not only confirm the presence of autophagic markers within cardiac myxomas but also suggest a possible association with their immune microenvironment.
Related Concept Videos
Myocarditis I: Introduction
The Tumor Microenvironment
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care

